Close Sidebar
Nordic Life Science
Now Reading
BioInvent selected to the Leukemia & Lymphoma Society’s Therapy Acceleration Program
Search for content, post, videos
Search for content, post, videos

BioInvent selected to the Leukemia & Lymphoma Society’s Therapy Acceleration Program

January 18, 2023
1285 Views
The partnership will include access to the scientific, clinical and drug development expertise of the Leukemia & Lymphoma Society (LLS) as well as a strategic capital equity investment from LLS TAP of 3 million USD. The acceleration program aims to advance the BioInvent International's progra
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.

Malin Otmani

Related Posts

Financing Super session
September 11, 2018

The Thuesday morning of NLSDays started off with a super session on Financing and both the expert panel and the presenting companies shared valuable insights. Starting and evolving a company requires funds and in this session, five Nordic life science companies at very different stages shared theAlready a subscriber Login…

agreement
January 29, 2016

PCI Biotech and Ultimovacs are initiating a preclinical research collaboration. The purpose of the collaboration is to utilise the companies’ complementary scientific platforms to explore potential synergies. Both companies are situated in the Oslo Cancer Cluster Incubator. The partnership Already a subscriber Login You have read all your free articles, to…

October 29, 2014

Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca. Shares in AstraZeneca fell 1.2 percent by 0800 GMT on Friday following the news. Pfizer is in the middle of a…

Jan Nilsson
January 10, 2023

The two companies have entered into a collaboration agreement regarding the continued development of Zyneyro's peptide- and AAV-based treatment of chronic pain conditions. The agreement with Zyneyro is a cooperation agreement that means that Zyneyro and CombiGene share the project’s costs and rAlready a subscriber Login You have read all…